Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | ERN1 | O75460 | 4/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.33 |
| ▸ | ABAT | P80404 | 1/20 | 0.33 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL646947 | 0.94 | ALDH1A1 (0.56) | ALDH1A1ERN1CYP2A6KDM4EPTGS2 | |
| SCHEMBL613761 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1 | |
| SCHEMBL21169399 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1 | |
| SCHEMBL19234310 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1 | |
| SCHEMBL237896 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1HSD17B10 | |
| SCHEMBL13893901 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1 | |
| SCHEMBL668005 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1KDM4EPTGS2RAB9A | |
| SCHEMBL1072176 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1 | |
| SCHEMBL1996468 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1CYP2A6ALDH1A3 | |
| SCHEMBL31039374 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 993 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | claimed |
| CN-116082591-B | Preparation method and application of three-dimensional covalent organic framework 3D COF material based on 8-communicated cubic ligand | 江苏科技大学 | 2025-02-25 | — | — | CN | claimed |
| CN-118652398-B | Crown ether-based porous organic polymer and preparation method and application thereof | 山东第二医科大学 | 2024-11-05 | — | — | CN | claimed |
| CN-118878455-A | Electronic transmission material based on 4,2', 6',4' -terpyridine and preparation method and application thereof | 电子科技大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118420856-B | Five-in-one combined antibacterial porphyrin cation covalent organic framework material and preparation method thereof | 山东第二医科大学 | 2024-09-27 | — | — | CN | claimed |
| CN-118652398-A | Crown ether-based porous organic polymer and preparation method and application thereof | 山东第二医科大学 | 2024-09-17 | — | — | CN | claimed |
| CN-118459420-A | Thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-118459422-A | Thiazole thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-118420856-A | Five-in-one combined antibacterial porphyrin cation covalent organic framework material and preparation method thereof | 山东第二医科大学 | 2024-08-02 | — | — | CN | claimed |
| CN-118359536-A | Novel-structure compound and application thereof in aspect of cryopreservation protection of stem cells | 南京泓纬医药科技有限公司 | 2024-07-19 | — | — | CN | claimed |
| US-20090209596-A1 | Oxazole Hydroxamic Acid Derivatives and Use Thereof | SK HOLDINGS CO., LTD | 2009-08-20 | — | — | US | claimed |
| EP-2056897-A1 | MEDICAL STENT PROVIDED WITH A COMBINATION OF MELATONIN AND PACLITAXEL | Blue Medical Devices B.V. (NL) | 2009-05-13 | — | — | EP | claimed |
| US-20080142370-A1 | Aqueous, Acidic Solution and Method for Electrolytically Depositing Copper Coatings as Well as Use of Said Solution | ATOTECH DEUTSCHLAND GMBH (DE) | 2008-06-19 | — | — | US | claimed |
| US-20080050413-A1 | Medical stent provided with a combination of melatonin and paclitaxel | BLUE MEDICAL DEVICES BV (NL) | 2008-02-28 | — | — | US | claimed |
| WO-2008023038-A1 | MEDICAL STENT PROVIDED WITH A COMBINATION OF MELATONIN AND PACLITAXEL | BLUE MEDICAL DEVICES BV (NL) | 2008-02-28 | — | — | WO | claimed |
| EP-1651801-B1 | AQUEOUS, ACIDIC SOLUTION AND METHOD FOR ELECTROLYTICALLY DEPOSITING COPPER COATINGS AS WELL AS USE OF SAID SOLUTION | ATOTECH DEUTSCHLAND GMBH (DE) | 2008-01-23 | — | — | EP | claimed |
| EP-1841747-A1 | OXAZOLE HYDROXAMIC ACID DERIVATIVES AND USE THEREOF | SK Corporation (KR) | 2007-10-10 | — | — | EP | claimed |
| WO-2006075888-A1 | OXAZOLE HYDROXAMIC ACID DERIVATIVES AND USE THEREOF | SK CORPORATION (KR) | 2006-07-20 | — | — | WO | claimed |
| EP-1390336-A1 | METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS | DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) | 2004-02-25 | — | — | EP | claimed |
| WO-2002096849-A1 | METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2002-12-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209596-A1 | Oxazole Hydroxamic Acid Derivatives and Use Thereof | HDAC1, HDAC5, HDAC7 | ALDH1A1 424/4885ERN1 3360/4885CYP2A6 2896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.